Ampio Pharmaceuticals' (AMPE -6%) issues a statement intended to reassure shareholders about...

Ampio Pharmaceuticals' (AMPE -6%) issues a statement intended to reassure shareholders about their plan to move to the NYSE, but it doesn't seem to be working. The response also attempted to address concerns raised in a Seeking Alpha blog entry recently posted by Greenwich Research that questions the stock's lofty valuation. AMPE states that the article "clearly intended to damage existing shareholders by triggering a downward pressure on their stock holdings."

From other sites
Comments (1)
  • bruinfan
    , contributor
    Comment (1) | Send Message
    I am astonished by your biased reporting! AMPIO issued a factual statement about the company to rebut the accusations of an anonymous contributor. Your characterization that "it doesn't seem to be working" is absurd. I've always found that stating the truth, in and by itself, works for the benefit of all shareholders. I couldn't see anywhere in the company response that the intention of the letter was for the stock to immediately go up. You seem to believe that the trading of a stock in a 3 hour window is determinative of the quality of the company.
    9 Jun 2013, 08:20 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs